ProCE Banner Activity

The Promise of Long-Acting Injectable Antiretroviral Therapies

Clinical Thought
Will long-acting cabotegravir plus rilpivirine injections satisfy patient desire for less frequent dosing? Here is my take.

Released: April 12, 2017

Expiration: April 11, 2018

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

ViiV Healthcare